Drs Kathy Miller and Francisco J. Esteva discuss testing and therapeutic options for the new classification of HER2-ultra-low breast cancer.

A Bangladeshi couple is facing visa challenges for their nine-month-old son's post-surgery checkup in Kolkata, India. Their ...

The parents could visit the hospital only once for a checkup following the surgery and one more physical consultation is ...

(NASDAQ:ARGX – Get Free Report) had its target price increased by equities research analysts at Wells Fargo & Company from ...

Androgen deprivation is the mainstay of advanced prostate cancer treatment. Despite initial responses, almost all patients progress to castration-resistant prostate cancer (CRPC). The ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced results from its Phase 2 study of suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal inhibitor in people with ...

competing successfully with other companies that are seeking to develop treatments for primary membranous nephropathy, immune ...

After hours: December 20 at 4:06:45 PM EST Loading Chart for ARGX ...

Impact and progress Frontiers' impact Progress Report 2022 All progress reports ...

Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including acute and ...

For the past couple of weeks, we have been looking at the Yeatts family of Kettle Hollow in Mayberry, Patrick County, ...